A novel multiregion hybridization assay reveals high frequency of dual inter-subtype infections among HIV-positive individuals in Cameroon, West Central Africa

Infection, Genetics and Evolution

Volumn 14, Issue 1, 2013, Pages 73-82

  Vidal, Nicole ^a   Diop, Halimatou ^b   Montavon, Céline ^a   Butel, Christelle ^a   Bosch, Stéphanie ^a   Ngole, Eitel Mpoudi ^c   Touré Kane, Coumba ^b   Mboup, Souleymane ^b   Delaporte, Eric ^a,d   Peeters, Martine ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b Centre Hospitalier Universitaire Aristide Le Dantec de Dakar   (Senegal)

^c Hôpital Militaire de Yaoundé   (Cameroon)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Dual infections; HIV 1 genetic diversity; Multi region hybridization assay

Indexed keywords

GAG PROTEIN; NEF PROTEIN;

ARTICLE; CAMEROON; CENTRAL AFRICA; CONTROLLED STUDY; GENE SEQUENCE; GENETIC VARIABILITY; GEOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYBRIDIZATION; LOW RISK POPULATION; MULTIREGION HYBRIDIZATION; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VIRUS STRAIN;

CAMEROON; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENOME, VIRAL; GENOTYPE; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; NUCLEIC ACID HYBRIDIZATION; PHYLOGENY; RECOMBINATION, GENETIC; SENSITIVITY AND SPECIFICITY; VIRAL REGULATORY AND ACCESSORY PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871899499     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.11.017     Document Type: Article

References (30)

1. Anisimova M., Gascuel O. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst. Biol. 2006, 55:539-552.
2. Braibant M., Xie J., Samri A., Agut H., Autran B., Barin F. Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strain. Virology 2010, 405:81-92.
3. Cornelissen M., Pasternak A.O., Grijsen M.L., Zorgdrager F., Bakker M., Blom P., Prins J.M., Jurriaans S., Van der Kuyl A.C. HIV-1 dual infection is associated with faster CD4+ T-cell decline in a cohort of men with primary HIV infection. Clin. Infect. Dis. 2012, 54:539-547.
4. Freitas F.B., Esteves A., Piedade J., Parreira R. Novel multi-region hybridization assay for the identification of the most prevalent genetic forms of the human immunodeficiency virus (HIV-1) circulating in Portugal. AIDS Res. Hum. Retroviruses 2012, 10.1089/AID.2012.0025.
5. Fultz P.N. HIV-1 superinfections: omens for vaccine efficacy?. AIDS 2004, 18:115-119.
6. Herbinger K.H., Gerhadt M., Piyasirisilp S., Mloka D., Arroyo M.A., Hoffmann O., Maboko L., Birx D.L., Mmbando D., McCutchan F.E., Hoelscher M. Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya region, Tanzania. AIDS Res. Hum. Retroviruses 2006, 22:599-606.
7. Hoelscher M., Dowling W.E., Sanders-Buell E., Carr J.K., Harris M.E., Thomschke A., Robb M.L., Birx D.L., McCutchan F.E. Detection of HIV-1 subtypes, recombinants, and dual infections in East Africa by a multi-region hybridization assay. AIDS 2002, 16:2055-2064.
8. Jung M., Leye N., Vidal N., Fargette D., Diop H., Kane C.T., Gascuel O., Peeters M. The origin and evolutionary history of HIV-1 subtype C in Senegal. PlosOne 2012, 7(3):e33579.
9. Kijak G.H., Sanders-Buell E., Wolfe N.D., Mpoudi-Ngole E., Kim B., Brown B., Robb M.L., Birx D.L., Burke D.S., Carr J.K., McCutchan F.E. Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa. AIDS Res. Hum. Retroviruses 2004, 20:521-530.
10. Kijak G.H., Tovanabutra S., Sanders-Buell E., Watanaveeradej V., de Souza M.S., Nelson K.E., Ketsararat V., Gulgolgarn V., Wera-arpachai M., Sriplienchan S., Khamboonrueng C., Birx D.L., Robb M.L., McCutchan F.E. Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v. 2. Virology 2007, 358:178-191.
11. Kozaczynska K., Cornelissen M., Reiss P., Zorgdrager F., Van der Kuyl A. HIV-1 sequence evolution in vivo after superinfection with three viral strains. Retrovirology 2007, 4:59.
12. Laurent C., Bourgeois A., Faye M.A., Mougnutou R., Seydi M., Gueye M., Liégeois F., Kane C.T., Butel C., Mbuagbaw J., Zekeng L., Mboup S., Mpoudi-Ngolé E., Peeters M., Delaporte E. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strains and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study. J. Infect. Dis. 2002, 186:486-492.
13. Lihana R.W., Ssemwanga D., Abimiku A., Ndembi N. Update on HIV-1 diversity in Africa: a decade in a review. AIDS Rev. 2012, 14:83-100.
14. Manigart O., Courgnaud V., Sanou O., Valea D., Nagot N., Meda N., Delaporte E., Peeters M., Van de Perre P. HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso as assessed by an autologous heteroduplex mobility procedure. AIDS 2004, 18:1645-1651.
15. Ndembi N., Iwamoto S., Ngansop C., Lemey P., Abimiku A., Mbanya D., Kaptue L.N., Ido E. High frequency of HIV-1 dual infections in Cameroon, West Central Africa. J. AIDS 2011, 57:e25-e27.
16. Njai H.F., Van der Auwera G., Ngong C.A., Heyndrickx L., Sawadago S., Whittle H., Nyambi P., Colebunders R., Van der Groen G., Janssens W. Development, evaluation, and validation of a oligonucleotide probe hybridization assay to subtype human immunodeficiency virus type 1 circulating recombinant form CRF02_AG. J. Clin. Microbiol. 2004, 42:1428-1433.
17. Powell R.L., Urbanski M.M., Burda S., Kinge T., Nyambi P.N. High frequency of dual infections among HIV-positive individuals in Cameroon, West Central Africa. J. AIDS 2009, 50:84-92.
18. Ragupathy V., Zhao J., Wood O., Tang S., Lee S., Nyambi P., Hewlett I. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon. Retrovirology 2011, 8:185.
19. Redd A.D., Mullis C.E., Serwadda D., Kong X., Martens C., Ricklefs S.M., Tobian A.A., Xiao C., Grabowski M.K., Nalugoda F., Kigozi G., Laeyendecker O., Kagaayi J., Sewankambo N., Gray R.H., Porcella S.F., Wawer M.J., Quinn T.C. The rates of HIV superinfection and primary HIV incidence in a general population in Rakai, Uganda. J. Infect Dis. 2012, 10.1093/infdis/jis325.
20. Rousseau C.M., Learn G.H., Bhattacharya T., Nickle D.C., Heckerman D., Chetty S., Brander C., Goulder P.J., Walker B.D., Kiepiela P., Korber B.T., Mullins J.I. Extensive intrasubtype recombination in South African HIV-1 subtype C infections. J. Virol. 2007, 81:4492-4500.
21. Sarkar R., Sengupta S., Mullick R., Singh N.B., Sarkar K., Chakrabarti S. Implementation of a multiregion hybridization assay to characterize HIV-1 strains detected among injecting drug users in Manipur, India. Intervirology 2009, 52:175-178.
22. Smyth, R.P., Davenport, M.P, Mak J., 2012. The origin of genetic diversity in HIV-1. Virus Res. http://dx.doi.org/10.1016/j.virusres.2012.06.015.
23. Teixeira D., Munerato P., Komninakis S.C.V., Fusuma E.E., Janini L.M., Sucupira M.C., Diaz R.S. The detection of in vivo and in vitro HIV type 1 B/F profiles in Brazil using a real-time PCR assay for five genomic regions. AIDS Res. Hum. Retroviruses 2010, 26:981-990.
24. Toure-Kane C., Montavon C., Faye M.A., Gueye P.M., Sow P.S., Ndoye I., Gaye-Diallo A., Delaporte E., Peeters M., Mboup S. Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence. AIDS Res. Hum. Retroviruses 2000, 16:603-609.
25. Van der Kuyl A.C., Cornelissen M. Identifying HIV-1 dual infections. Retrovirology 2007, 4:67.
26. Vergne L., Bourgeois A., Mpoudi-Ngole E., Mougnutou R., Mbuagbaw J., Liegeois F., Laurent C., Butel C., Zekeng L., Delaporte E., Peeters M. Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage. Virology 2003, 310:254-266.
27. Vergne L., Diagbouga S., Kaouanfack C., Aghokeng A., Butel C., Laurent C., Noumssi N., Tardy M., Sawadogo A., Drabo J., Hien H., Zekeng L., Delaporte E., Peeters M. HIV-1 drug resistance mutations among newly diagnosed patients before scaling-up programs in Burkina Faso and Cameroon. Antivir. Ther. 2006, 11:575-579.
28. Vidal N., Niyongabo T., Nduwimana J., Butel C., Ndayirague A., Wakana J., Nduwimana M., Delaporte E., Peeters M. HIV type 1 diversity and antiretroviral drug resistance mutations in Burundi. AIDS Res. Hum. Retroviruses 2007, 23:175-180.
29. Vidal N., Bazepeo S.E., Mulanga C., Delaporte E., Peeters M. Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new sub-subtype, A5, in the A radiation that predominates in the recombinant structure of CRF26_A5U. AIDS Res. Hum. Retroviruses 2009, 25:823-832.
30. Zhang M., Foley B., Schultz A.K., Macke J.P., Bulla I., Stanke M., Morgenstern B., Korber B., Leitner T. The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology 2010, 7:25.